TrialBritish journal of haematology2016

Long-term durable remission by cladribine followed by rituximab in patients with hairy cell leukaemia: update of a phase II trial.

Dai Chihara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.